Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer

被引:0
作者
M. Wada
M. Yamamoto
S. Ryuge
Y. Nagashima
N. Hayashi
S. Maki
S. Otani
K. Katono
A. Takakura
T. Yanaihara
S. Igawa
M. Yokoba
H. Mitsufuji
M. Kubota
M. Katagiri
N. Masuda
机构
[1] Kitasato University School of Medicine,Department of Respiratory Medicine
[2] Kitasato University School of Allied Health Sciences,Department of Clinical Physiology
来源
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词
S-1; Non-small-cell lung cancer; Second-line chemotherapy; Phase II study; Oral cytotoxic agent; EGFR mutation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1005 / 1011
页数:6
相关论文
共 190 条
  • [41] Uno T(undefined)undefined undefined undefined undefined-undefined
  • [42] Taguchi T(undefined)undefined undefined undefined undefined-undefined
  • [43] Shirasaka M(undefined)undefined undefined undefined undefined-undefined
  • [44] Kawahara K(undefined)undefined undefined undefined undefined-undefined
  • [45] Furuse Y(undefined)undefined undefined undefined undefined-undefined
  • [46] Segawa K(undefined)undefined undefined undefined undefined-undefined
  • [47] Yoshimori K(undefined)undefined undefined undefined undefined-undefined
  • [48] Matsui S(undefined)undefined undefined undefined undefined-undefined
  • [49] Kudoh K(undefined)undefined undefined undefined undefined-undefined
  • [50] Hasegawa H(undefined)undefined undefined undefined undefined-undefined